Rivaroxaban, in combination with low-dose aspirin, is associated with a reduction in proinflammatory and prothrombotic circulating vesicle signatures in patients with cardiovascular disease

Luisa Weiß, Patricia B. Maguire|Journal of Thrombosis and Haemostasis|2024

Cited by 10